YDES · YD Bio Ltd
$2.27
+0.00 (+0.00%)
At close · Jul 21
Market Cap
$156.54M
Shares
70.83M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$596.82K
+16.9%
FY2025
Net Income
-$8.31M
-488.8%
FY2025
Gross Margin
28.05%
-2.4pp
FY2025
Operating Margin
-883.31%
-596.9pp
FY2025
Diluted EPS
-$0.12
-500%
FY2025
Operating Cash Flow
-$6.6M
-439.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| $596.82K | $510.36K | $350.13K | |
| $429.41K | $355K | $196.69K | |
| $167.41K | $155.36K | $153.45K | |
| 28.05% | 30.44% | 43.83% | |
| $1.6M | $491.35K | — | |
| $170.52K | $1957 | $7492 | |
| $3.66M | $1.12M | $153.07K | |
| $5.44M | $1.62M | $163.29K | |
| -$5.27M | -$1.46M | -$9847 | |
| -883.31% | -286.45% | -2.81% | |
| — | $772 | $2144 | |
| $80.16K | $11.81K | $290 | |
| -$3.04M | $75.45K | $27.5K | |
| -$8.31M | -$1.39M | $17.65K | |
| -$1531 | $25.08K | $4090 | |
| -$8.31M | -$1.41M | $13.56K | |
| -1392.61% | -276.58% | 3.87% | |
| -$8.14M | -$1.41M | $13.66K | |
| USD/shares | -$0.12 | -$0.02 | $0.00 |
| USD/shares | -$0.12 | -$0.02 | $0.00 |
| shares | 66.72M | 64.73M | 64.73M |
| shares | 66.72M | 64.73M | 64.73M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 |
|---|---|
| Taiwan | $561,817 |
| United States | $35,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Sales of Medical and Other Related Products | $561,817 | — | — |
| Medical and Related Products | $280,774 | $292,858 | $146,850 |
| Drugs | $223,425 | $143,633 | $141,947 |
| Beauty Products | $49,911 | — | — |
| Contact Lenses | $35,000 | — | — |
| Research and Development of Sales of Contact Lenses | $35,000 | — | — |
| Nutritional Products | $5,234 | $41,772 | $9,540 |
| Supplements | $2,473 | $32,097 | $51,794 |